A detailed history of Park Place Capital Corp transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Park Place Capital Corp holds 13 shares of JAZZ stock, worth $1,598. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13
Previous 73 82.19%
Holding current value
$1,598
Previous $7,000 85.71%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

SELL
$100.57 - $116.37 $6,034 - $6,982
-60 Reduced 82.19%
13 $1,000
Q2 2024

Jul 02, 2024

SELL
$103.94 - $118.98 $2,182 - $2,498
-21 Reduced 22.34%
73 $7,000
Q1 2024

Apr 18, 2024

SELL
$115.19 - $132.77 $345 - $398
-3 Reduced 3.09%
94 $11,000
Q4 2023

Jan 24, 2024

BUY
$114.26 - $136.0 $914 - $1,088
8 Added 8.99%
97 $11,000
Q1 2023

May 02, 2023

SELL
$133.98 - $160.47 $1,473 - $1,765
-11 Reduced 11.0%
89 $13,000
Q4 2022

Feb 14, 2023

BUY
$129.72 - $159.85 $12,972 - $15,985
100 New
100 $16,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Park Place Capital Corp Portfolio

Follow Park Place Capital Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Park Place Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Park Place Capital Corp with notifications on news.